Bladder Clear Cell Adenocarcinoma trials recruiting in District of Columbia

Fewer than 3 recruiting trials found.

All Bladder Clear Cell Adenocarcinoma trials nationally

Cities in District of Columbia

Recruiting trials in District of Columbia

• Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
  NCT03866382 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.